Liwanli Innovation Co (TPE:3054) Construction In Progress : NT$0.00 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Liwanli Innovation Co Construction In Progress?

Liwanli Innovation Co Construction In Progress Historical Data

The historical data trend for Liwanli Innovation Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liwanli Innovation Co Construction In Progress Chart

Liwanli Innovation Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

Liwanli Innovation Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															-	-	-	-	-

Liwanli Innovation Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Liwanli Innovation Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Liwanli Innovation Co Ltd (TPE:3054) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

Liancheng Road, No. 258, 18th Floor - 9, Zhonghe District, New Taipei City, TWN, 235

Website

https://www.liwanli.com.tw

Liwanli Innovation Co Ltd is engaged in the manufacture, wholesale, and retail of electronic materials and the sales of biotech products like drug nutrient products. The reportable segments of the company are distinguished by products; the electronic department is mainly engaged in the sale and after-sales service of computer peripherals, memory and other related products; and the biotechnology department is mainly engaged in the sales of biotechnology products. Maximum revenue is generated from its Electronics department. Geographically, the company generates a majority of its revenue from Taiwan, followed by other regions.

Liwanli Innovation Co Headlines

No Headlines